Emily C. Hartman
- Hematology top 2%
- Multiple Myeloma Research and Treatments 2
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
- Oncology top 10%
- Genetics top 10%
- Evolution and Genetic Dynamics 3
-
- Bacteriophages and microbial interactions 6
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Ultrasound and Hyperthermia Applications 2
- Co-authors
- Monica SchenoneSteven A. CarrPeter GraumanDirk HecklStuart L. SchreiberNamrata D. UdeshiNikhil C. MunshiBenjamin L. Ebert
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- Science (1 paper)Journal of the American Chemical Society (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesBrazilRussia
In The Last Decade
Emily C. Hartman
16 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 589
- Molecular Biology 1.3k
- Oncology 450
- Genetics 83
- Immunology 157
Countries citing papers authored by Emily C. Hartman
This map shows the geographic impact of Emily C. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily C. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily C. Hartman more than expected).
Fields of papers citing papers by Emily C. Hartman
This network shows the impact of papers produced by Emily C. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily C. Hartman. The network helps show where Emily C. Hartman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily C. Hartman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2020 | 12 | |
| 5 | 2019 | 26 | |
| 6 | 2019 | 11 | |
| 7 | 2019 | 20 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 42 | |
| 10 | 2018 | 71 | |
| 11 | 2016 | 30 | |
| 12 | 2016 | 31 | |
| 13 | 2016 | 43 | |
| 14 | 2014 | 49 | |
| 15 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cellsbreakdown → | 2013 | 1288 |
| 16 | 2013 | 1 | |
| 17 | 2012 | 10 | |
| 18 | 2011 | 3 |
About Emily C. Hartman
Emily C. Hartman is a scholar working on Radiology, Nuclear Medicine and Imaging, Ecology and Hematology, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bacteriophages and microbial interactions (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Protein Degradation and Inhibitors (3 papers), Evolution and Genetic Dynamics (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Multiple Myeloma Research and Treatments (2 papers), Ultrasound and Hyperthermia Applications (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (589 citations), Molecular Biology (1.3k citations) and Oncology (450 citations). Emily C. Hartman has collaborated with scholars based in United States, Brazil and Russia. Frequent co-authors include Monica Schenone, Steven A. Carr, Peter Grauman, Dirk Heckl, Stuart L. Schreiber, Namrata D. Udeshi, Nikhil C. Munshi, Benjamin L. Ebert, Eamon Comer and Marie McConkey. Their work appears in journals such as Science, Journal of the American Chemical Society and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.